Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-13-001040
Filing Date
2013-09-24
Accepted
2013-09-24 18:42:21
Documents
1
Period of Report
2013-09-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2804
  Complete submission text file 0000904454-13-001040.txt   4205
Mailing Address 12555 HIGH BLUFF DRIVE SUITE 385 San Diego CA 92130
Business Address 12555 HIGH BLUFF DRIVE SUITE 385 San Diego CA 92130 (760) 487-1255
Evoke Pharma Inc (Issuer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DOMAIN ASSOCIATES, L.L.C. ONE PALMER SQUARE, SUITE 515 PRINCETON NJ 08542
Business Address
Kamdar Kim P. (Reporting) CIK: 0001535065 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36075 | Film No.: 131113086